There are 3161 resources available
New perspectives in the post IO setting
Presenter: Manuela Schmidinger
Session: Eisai Inc. - Evolving Treatment Sequence for Renal Cell Carcinoma
Resources:
Webcast
Burning questions: what riddles remain?
Presenter: Laurence Albiges, Jens Bedke, Guillermo Antonio De Velasco Oria, Sumanta Pal
Session: Ipsen - Kidney cancer puzzles – from insights to progress
Resources:
Webcast
A glimpse of the future: Ongoing research on novel therapeutics for advanced breast cancer patients post-progression on endocrine+CDK4/6-inhibition
Presenter: Joyce O'Shaughnessy
Session: ESMO Colloquium supported by Eli Lilly and Company - Hormone-receptor (+), HER2 (-) advanced breast cancer: The biology and treatment landscape post-progression after CDK4/6 inhibition
Resources:
Slides
Webcast
Round table case discussions, Q&A
Presenter: Toni Choueiri
Session: Eisai Inc. - Evolving Treatment Sequence for Renal Cell Carcinoma
Resources:
Webcast
Closing Remarks
Presenter: Laurence Albiges
Session: Ipsen - Kidney cancer puzzles – from insights to progress
Resources:
Webcast
Q&A and discussion
Session: ESMO Colloquium supported by Eli Lilly and Company - Hormone-receptor (+), HER2 (-) advanced breast cancer: The biology and treatment landscape post-progression after CDK4/6 inhibition
Resources:
Webcast
Summary and key takeaways
Presenter: Manuela Schmidinger
Session: Eisai Inc. - Evolving Treatment Sequence for Renal Cell Carcinoma
Resources:
Webcast
Concluding remarks
Presenter: Cristina Saura Manich
Session: ESMO Colloquium supported by Eli Lilly and Company - Hormone-receptor (+), HER2 (-) advanced breast cancer: The biology and treatment landscape post-progression after CDK4/6 inhibition
Resources:
Webcast
Presentation by Expert
Presenter: Anna Sophie Berghoff
Session: Is it possible to treat brain metastases without RT in 2024?
Resources:
Slides
Webcast
Discussion led by Chair
Presenter: Evangelia Razis
Session: Is it possible to treat brain metastases without RT in 2024?
Resources:
Webcast